Literature DB >> 10751785

Advances in Alliteration in Acute Myocardial Infarction: From "Time to Treatment" to "Onset to Opening"

.   

Abstract

Entities:  

Year:  1998        PMID： 10751785     DOI： 10.1023/A:1008818103943

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  16 in total

1.  Time to Reperfusion: The Critical Modulator in Thrombolysis and Primary Angioplasty.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

3.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

Authors:  E Braunwald
Journal:  Circulation       Date:  1989-02       Impact factor: 29.690

4.  Treating myocardial infarction: importance of early reperfusion.

Authors:  C L Grines; W D Weaver
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

5.  More on the GUSTO trial.

Authors:  E J Topol; R M Califf; K L Lee
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

6.  Time as an Adjunctive Agent to Thrombolytic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

7.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

8.  Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.

Authors:  C P Cannon; C H McCabe; D J Diver; S Herson; R M Greene; P K Shah; R F Sequeira; F Leya; J M Kirshenbaum; R D Magorien
Journal:  J Am Coll Cardiol       Date:  1994-12       Impact factor: 24.094

9.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

10.  Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis.

Authors:  A C Pell; H C Miller; C E Robertson; K A Fox
Journal:  BMJ       Date:  1992-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.